PKC alpha antibody (AA 305-325)
Quick Overview for PKC alpha antibody (AA 305-325) (ABIN2342863)
Target
See all PKC alpha (PKCa) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 305-325
-
Sequence
- FEKAKLGPAG NKVISPEDRK Q
-
Cross-Reactivity
- Human, Mammalian
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu Ma
-
Characteristics
- Protein Kinase C, alpha (AAG6, MGC129900, MGC129901, PKCA, PKC-A, PKC-alpha, PRKACA, Protein kinase C alpha type)
-
Immunogen
- Synthetic peptide corresponding to a distinct C-terminal region, (FEKAKLGPAGNKVISPEDRKQ residues 305-325) from human protein kinase C alpha.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as antiserum containing 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))
-
Alternative Name
- Protein Kinase C, alpha
-
UniProt
- P17252
-
Pathways
- WNT Signaling, TCR Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-